With 1.06 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.2 million shares. The 52-week range on CYTO shows that it touched its highest point at $52.00 and its lowest point at $1.61 during that stretch. It currently has a 1-year price target of $287.34. Beta for the stock currently stands at 2.51.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CYTO was up-trending over the past week, with a rise of 44.05%, but this was up by 31.52% over a month. Three-month performance dropped to -15.09% while six-month performance fell -51.07%. The stock lost -90.69% in the past year, while it has lost -30.46% so far this year.
Float and Shares Shorts:
At present, 1.58 million CYTO shares are outstanding with a float of 1.58 million shares on hand for trading. On Feb 29, 2024, short shares totaled 56580.0, which was 3.59% higher than short shares on Jan 31, 2024. In addition to CYDY as the firm’s CYTODYN INC, CYTO serves as its Altamira Therapeutics Ltd.
Institutional Ownership:
Through their ownership of 0.49% of CYTO’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CYTO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Dividends & Yield:
In terms of dividends, CYTO has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and CYTO currently yields $0.00. In the past year, CYTO’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, CYTO has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.
